The latest update is out from PDS Biotechnology ( (PDSB) ).

The incidence of HPV16-related cancers is rapidly increasing in the US and Europe and also increasing globally.* PDS0101 is currently being studied in the Company’s Phase 3 trial for PDS0101 + ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice.

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...

Notably, the Huntsville site will be among those that will manufacture orforglipron, Lilly’s first oral, small molecule GLP-1 ...

For pharmaceutical firms, watching the lucrative patents on their top-selling drugs expire has long been part of the business ...

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ...

During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion ...